流感大流行期间检测阴性设计疫苗效果估计的偏倚
该研究用动态概率模型评估流感大流行期间检测阴性(TN)设计中流感疫苗效果(VE)估计的偏倚。模型纳入健康状态和健康意识两个协变量,考察疫苗接种在暴发开始后发生时的多种偏倚来源。结果显示,若TN设计核心假设满足(接种不影响非流感急性呼吸道感染概率),针对就诊流感的VE估计仅受小到中等偏倚。
要点
- 大流行期间接种延迟对VE估计的影响不可预测。
- 若接种不影响非流感ARI概率,TN设计针对就诊流感的偏倚较小。
- 上述偏倚来源排除后,TN设计在大流行期间仍属有效。
核心结论
- 大流行期间接种开始时,TN研究的VE估计在存在任何偏倚来源时均有偏倚。
- 若TN设计核心假设满足,针对就诊流感的VE估计仅受小(<0.05)到中等(≥0.05且<0.10)偏倚。
- 排除所列偏倚来源后,TN设计可用于大流行期间VE估计。
研究设计与样本
- 使用动态概率模型评估TN设计VE估计的偏倚。
- 模型包含健康状态和健康意识两个协变量。
- 评估四种偏倚来源下VE估计的偏倚。
- 考虑两种疫苗保护结局:症状性流感和就诊流感。
主要发现
- 疫苗接种在暴发开始后发生时,接种延迟对VE估计的影响不可预测。
- 无论存在何种偏倚来源,TN研究的VE估计均有偏倚。
- 若接种不影响非流感ARI概率,针对就诊流感的VE估计偏倚为小(<0.05)到中等(≥0.05且<0.10)。
关键数值与推荐
- 偏倚小定义为<0.05,中等偏倚定义为≥0.05且<0.10。
- 核心假设:疫苗接种不影响非流感急性呼吸道感染的概率。
临床怎么用
- 在大流行期间使用TN设计估计VE时,应评估并排除所列偏倚来源。
- 若核心假设满足,TN设计估计的就诊流感VE偏倚较小,可谨慎解读。
局限性
- 结果为基于动态概率模型的模拟评估,未报告实际数据验证。
- 未报告模型参数的具体取值和样本量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Test-negative (TN) studies have become the most widely used study design for the estimation of influenza vaccine effectiveness (VE) and are easily incorporated into existing influenza surveillance networks. We seek to determine the bias of TN-based VE estimates during a pandemic using a dynamic probability model. The model is used to evaluate and compare the bias of VE estimates under various sources of bias when vaccination occurs after the beginning of an outbreak, such as during a pandemic. The model includes two covariates (health status and health awareness), which may affect the probabilities of vaccination, developing influenza and non-influenza acute respiratory illness (ARI), and seeking medical care. Specifically, we evaluate the bias of VE estimates when (1) vaccination affects the probability of developing a non-influenza ARI; (2) vaccination affects the probability of seeking medical care; (3) a covariate (e.g. health status) is related to both the probabilities of vaccination and developing an ARI; and (4) a covariate (e.g. health awareness) is related to both the probabilities of vaccination and of seeking medical care. We considered two outcomes against which the vaccine is supposed to protect: symptomatic influenza and medically-attended influenza. When vaccination begins during an outbreak, we found that the effect of delayed onset of vaccination is unpredictable. VE estimates from TN studies were biased regardless of the source of bias present. However, if the core assumption of the TN design is satisfied, that is, if vaccination does not affect the probability of non-influenza ARI, then TN-based VE estimates against medically-attended influenza will only suffer from small (<0.05) to moderate bias (≥0.05 and <0.10). These results suggest that if sources of bias listed above are ruled out, TN studies are a valid study design for the estimation of VE during a pandemic.
引用
- Ainslie KEC, Haber M, Orenstein WA, et al. Bias of influenza vaccine effectiveness estimates from test-negative studies conducted during an influenza pandemic. Vaccine. 2019. PMID: 30833155. doi:10.1016/j.vaccine.2019.02.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。